Convertible Notes and Loan Agreement (Details Narrative) - USD ($)					9 Months Ended	12 Months Ended
	Feb. 26, 2025	Oct. 21, 2024	Oct. 14, 2024	Jan. 11, 2023	Sep. 30, 2025	Dec. 31, 2025	Dec. 31, 2024	Oct. 21, 2025	Oct. 14, 2025	Feb. 27, 2025	Oct. 31, 2024	Aug. 13, 2024	Aug. 06, 2024
Short-Term Debt [Line Items]
Convertible notes payable				$ 10,000,000
Proceeds from convertible note payable							$ 790,000
Repayment of convertible note							846,806
Loss on issuance of convertible note							16,758
Issuance costs						557,659	235,707
Fair value of common stock per share												$ 1.00
Allocation of financing costs						74,152	107,491
Warrant derivative liability						99,687	25,281
Legal fees						2,189,199	2,684,665
Amortization of debt discount						62,030	1,079,444
Debt, principal							800,000
Interest paid							100,000
Payment including principal and accrued interest							900,000
Loss on settlement of convertible debt							800,000
Common Stock [Member]
Short-Term Debt [Line Items]
Debt, principal							1,900,000
Boustead Securities LLC [Member]
Short-Term Debt [Line Items]
Warrants to purchase common stock				357
Warrants exerciable shares				$ 470.00
Payment for placement agent				$ 345,000
Fair value of warrants				99,543
Allocation of financing costs				232,027
Warrant derivative liability				104,245
Equity warrant as reduction in additional paid in capital				$ 8,727
Boustead Securities LLC [Member] \| Measurement Input, Expected Term [Member]
Short-Term Debt [Line Items]
Expected years				5 years
Boustead Securities LLC [Member] \| Measurement Input, Price Volatility [Member]
Short-Term Debt [Line Items]
Warrants and rights outstanding measurement input				110
Boustead Securities LLC [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Short-Term Debt [Line Items]
Warrants and rights outstanding measurement input				3.53
Convertible Bridge Notes [Member]
Short-Term Debt [Line Items]
Debt interest rate			107.00%
Effective interest rate			14.50%
Convertible notes payable			$ 600,000
Original issue discount percentage		5.00%	5.00%
Issuance of debt		$ 220,000	$ 570,000			806,758
Secured debt		231,579
Proceeds from secured debt		$ 790,000
Loss on issuance of convertible note						$ 16,758
Issuance costs					$ 107,491
Debt discount					$ 41,579
Settlements in form of shares						117,612
Fair value of common stock per share								$ 3.47	$ 3.92
Debt, principal						$ 831,579
Convertible Bridge Notes [Member] \| Dr. Anatoly Dritschilo [Member]
Short-Term Debt [Line Items]
Proceeds from convertible note payable			237,500
Repayment of convertible note			$ 250,000
Convertible Bridge Notes [Member] \| Lenders [Member]
Short-Term Debt [Line Items]
Warrants to purchase common stock		3,543	9,639								9,639
Warrants exerciable shares		$ 37.25	$ 35.00								$ 35.00
Expected years		5 years	5 years
Convertible Bridge Notes [Member] \| Maximum [Member]
Short-Term Debt [Line Items]
Convertible notes payable			$ 1,300,000
Alto Convertible Note [Member]
Short-Term Debt [Line Items]
Debt principal amount				$ 1,442,000
Interest expense				3,310,543		1,200,000
Debt discount				300,000
Fair value of warrants				1,288,543
Legal fees				65,000
Interest fee				$ 215,000
Cash collateral													$ 600,000
Convertible notes													$ 1,200,000
Payment for expenses	$ 75,000
Option to purchase convertible notes and warrants	$ 10,000,000
Amortization of debt discount							1,100,000
Principal, settled							1,400,000
Accrued interest, settled							$ 100,000
Alto Convertible Note [Member] \| Common Stock [Member]
Short-Term Debt [Line Items]
Settlements in form of shares							31,894
Revolving Note Agreement [Member]
Short-Term Debt [Line Items]
Debt principal amount										$ 2,000,000
Debt interest rate										18.00%
Deferred loan costs										$ 78,000
Interest expense						62,030
Effective interest rate										120.00%
Balance outstanding						0
Securities Purchase Agreement [Member]
Short-Term Debt [Line Items]
Debt interest rate				5.00%
Effective interest rate				346.00%
Warrants to purchase common stock				5,091
Warrants exerciable shares				$ 470.00
Proceeds from convertible note payable				$ 3,935,000
Convertible debt				$ 4,300,000		$ 0
Debt description				the Alto Convertible Note was convertible into shares of common stock at a price per share equal to the lower of (i) $470.00 per share, as adjusted, (ii) 90% of the three lowest daily VWAPs of the 15 trading days prior to the payment date, or (iii) 90% of the VWAP of the trading day prior to payment date.
Derivative liability				$ 1,442,000
Securities Purchase Agreement [Member] \| March 2025 Equity Financings [Member]
Short-Term Debt [Line Items]
Warrants exerciable shares				$ 3.38
Securities Purchase Agreement [Member] \| June 2025 Equity Financings [Member]
Short-Term Debt [Line Items]
Warrants exerciable shares				$ 3.38

Shuttle Pharmaceuticals Holdings, Inc. 10-K